BFOCX
Price
$28.75
Change
+$0.61 (+2.17%)
Updated
Feb 28 closing price
Net Assets
254.36M
FSPTX
Price
$35.17
Change
+$0.65 (+1.88%)
Updated
Feb 28 closing price
Net Assets
16.08B
Ad is loading...

BFOCX vs FSPTX

Header iconBFOCX vs FSPTX Comparison
Open Charts BFOCX vs FSPTXBanner chart's image
Berkshire Focus
Price$28.75
Change+$0.61 (+2.17%)
VolumeN/A
Net Assets254.36M
Fidelity Select Technology
Price$35.17
Change+$0.65 (+1.88%)
VolumeN/A
Net Assets16.08B
BFOCX vs FSPTX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BFOCX vs. FSPTX commentary
Mar 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BFOCX is a Hold and FSPTX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
FSPTX has more cash in the bank: 16.1B vs. BFOCX (254M). FSPTX pays higher dividends than BFOCX: FSPTX (0.01) vs BFOCX (0.00). BFOCX was incepted earlier than FSPTX: BFOCX (28 years) vs FSPTX (44 years). BFOCX is a more actively managed with annual turnover of: 1613.90 vs. FSPTX (24.00). FSPTX has a lower initial minimum investment than BFOCX: FSPTX (0) vs BFOCX (5000). BFOCX annual gain was more profitable for investors over the last year : 29.91 vs. FSPTX (10.81). FSPTX return over 5 years is better than : 79.26 vs. BFOCX (-2.11).
BFOCXFSPTXBFOCX / FSPTX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence28 years44 years-
Gain YTD-4.927-4.637106%
Front LoadN/AN/A-
Min. Initial Investment50000-
Min. Initial Investment IRAN/AN/A-
Net Assets254M16.1B2%
Annual Yield % from dividends0.000.01-
Returns for 1 year29.9110.81277%
Returns for 3 years5.3144.3412%
Returns for 5 years-2.1179.26-3%
Returns for 10 years54.24190.8228%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PBDC36.170.56
+1.57%
Putnam BDC Income ETF
CVMC60.100.63
+1.06%
Calvert US Mid-Cp Cor Rspnb ETF
CNCR11.380.12
+1.05%
Range Cancer Therapeutics ETF
GRPM107.850.87
+0.81%
Invesco S&P MidCap 400® GARP ETF
NVG12.910.05
+0.39%
Nuveen AMT-Free Municipal Credit Income Fund